The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Human papillomavirus prevalence and type distribution in penile carcinoma
Abstract
Background: Penile carcinoma is an uncommon and potentially mutilating disease with a heterogeneous aetiology. Several risk factors have been established for its development. Human papillomavirus (HPV) infection seems to play an important role in the development of a subset of these carcinomas and its presence is thought to be related to the histological type. HPV prevalence in penile tumours is reported to be associated to a variety of morphological changes. Its determination will provide a better estimate for HPV related cancer burden and its preventable fraction. Methods: A systematic and comprehensive literature review of the major penile cancer studies published from 1986 until June 2008 evaluating the HPV prevalence among the different histological types was carried out. Results: 31 studies including 1466 penile carcinomas were reviewed. Global HPV prevalence was 46.9%. Relative contribution was: HPV-16 (60.23%), HPV-18 (13.35%), HPV-6/11 (8.13%), HPV-31 (1.16%), HPV-45 (1.16%), HPV-33 (0.97%), HPV-52 (0.58%), other types (2.47%). Assessment of multiple infections contribution is limited due to study design. Basaloid and warty squamous cell carcinomas were the most frequent HPV-related histological types, but keratinising and non-keratinising subtypes also showed prevalence rates of around 50%. Conclusions: About half of the penile tumours were associated with HPV 16–18 with little presence of other genotypes. Research on the mechanisms behind penile carcinogenesis is warranted. Available HPV vaccines are likely to be effective in penile tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chapter 2: The burden of HPV-related cancers
Parkin, D. M., & Bray, F. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.111 · Cited by 1,385
Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners
Castellsagué, X., Bosch, F. X., Muñoz, N., Meijer, C. J. L. M., Shah, K. V., de Sanjosé, S., Eluf-Neto, J., Ngelangel, C. A., Chichareon, S., Smith, J. S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011688 · Cited by 804
Self-citationBlock, S. L., Nolan, T., Sattler, C., Barr, E., Giacoletti, K. E. D., Marchant, C. D., Castellsagué, X., Rusche, S. A., Lukac, S., Bryan, J. T., et al. (2006) · Pediatrics · doi:10.1542/peds.2006-0461 · Cited by 484
Daling, J. R., Madeleine, M. M., Johnson, L. G., Schwartz, S. M., Shera, K. A., Wurscher, M. A., Carter, J. J., Porter, P. L., Galloway, D. A., McDougall, J. K., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21009 · Cited by 446
Detection and Typing of Human Papillomavirus DNA in Penile Carcinoma
Rubin, M. A., Kleter, B., Zhou, M., Ayala, G., Cubilla, A. L., Quint, W. G. V., & Pirog, E. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62506-0 · Cited by 429
Self-citationHistory of Circumcision, Medical Conditions, and Sexual Activity and Risk of Penile Cancer
Maden, C., Sherman, K. J., Beckmann, A. M., Hislop, T. G., Teh, C.-Z., Ashley, R. L., & Daling, J. R. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.1.19 · Cited by 426
Penile cancer: epidemiology, pathogenesis and prevention
Bleeker, M. C. G., Heideman, D. A. M., Snijders, P. J. F., Horenblas, S., Dillner, J., & Meijer, C. J. L. M. (2009) · World Journal of Urology · doi:10.1007/s00345-008-0302-z · Cited by 369
Lont, A. P., Kroon, B. K., Horenblas, S., Gallee, M. P. W., Berkhof, J., Meijer, C. J. L. M., & Snijders, P. J. F. (2006) · International Journal of Cancer · doi:10.1002/ijc.21961 · Cited by 249
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
Carter, J. J., Madeleine, M. M., Shera, K. A., Schwartz, S. M., Cushing‐Haugen, K. L., Wipf, G. C., Porter, P. L., Daling, J. R., McDougall, J. K., & Galloway, D. A. (2001) · PubMed · Cited by 182
Epidemiology of Human Papillomavirus Infection
Dillner, J., Meijer, C. J. L. M., von Krogh, G., & Horenblas, S. (2000) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590050509922 · Cited by 177
Cited by
Role of Human Papillomavirus in Penile Carcinomas Worldwide
Alemany, L., Cubilla, A., Halec, G., Kasamatsu, E., Quirós, B., Masferrer, E., Tous, S., Lloveras, B., Hernández-Suarez, G., Lonsdale, R., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.12.007 · Cited by 299
Self-citationCancer in Africa 2018: The role of infections
Parkin, D. M., Hämmerl, L., Ferlay, J., & Kantelhardt, E. J. (2020) · International Journal of Cancer · doi:10.1002/ijc.32538 · Cited by 130
Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
Riethmuller, D., Jacquard, A.-C., Lacau St Guily, J., Aubin, F., Carcopino, X., Pradat, P., Dahlab, A., & Prétet, J.-L. (2015) · BMC Public Health · doi:10.1186/s12889-015-1779-1 · Cited by 61
Metadata
- Authors
- Miralles-Guri, C., Bruni, L., Cubilla, A. L., Castellsagué, X., Bosch, F. X., & de Sanjosé, S.
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 2009-08-25
- Volume
- 62
- Issue
- 10
- Pages
- 870-878
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- OpenAlex
- W2005777124
- Cited by
- 332
- References
- 29
- FWCI
- 27.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human papillomavirus prevalence and type distribution in penile carcinoma. https://app.cochat.ai/papers/10.1136/jcp.2008.063149
- The paper
- Miralles-Guri, C., Bruni, L., Cubilla, A. L., Castellsagué, X., Bosch, F. X., & de Sanjosé, S. (2009). Human papillomavirus prevalence and type distribution in penile carcinoma. Journal of Clinical Pathology. https://doi.org/10.1136/jcp.2008.063149
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
